vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Canaan Inc. (CAN). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $20.8M, roughly 1.0× Canaan Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -373.3%, a 354.9% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
AUTL vs CAN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $20.8M |
| Net Profit | $-79.1M | $-3.8M |
| Gross Margin | — | 99.9% |
| Operating Margin | -337.9% | -15.9% |
| Net Margin | -373.3% | -18.4% |
| Revenue YoY | — | — |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $20.8M | ||
| Q3 25 | $21.2M | $13.8M | ||
| Q2 25 | $20.9M | $11.4M | ||
| Q1 25 | $9.0M | — | ||
| Q3 24 | $0 | $10.2M | ||
| Q2 24 | $0 | $4.8M | ||
| Q1 24 | $10.1M | — |
| Q4 25 | — | $-3.8M | ||
| Q3 25 | $-79.1M | $-1.5M | ||
| Q2 25 | $-47.9M | $-11.9M | ||
| Q1 25 | $-70.2M | — | ||
| Q3 24 | $-82.1M | $-10.4M | ||
| Q2 24 | $-58.3M | $-5.4M | ||
| Q1 24 | $-52.7M | — |
| Q4 25 | — | 99.9% | ||
| Q3 25 | — | 99.9% | ||
| Q2 25 | — | 99.9% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 99.9% | ||
| Q2 24 | — | 99.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | -15.9% | ||
| Q3 25 | -337.9% | -27.0% | ||
| Q2 25 | -292.6% | -45.5% | ||
| Q1 25 | -726.3% | — | ||
| Q3 24 | — | -77.2% | ||
| Q2 24 | — | -193.9% | ||
| Q1 24 | -384.1% | — |
| Q4 25 | — | -18.4% | ||
| Q3 25 | -373.3% | -11.0% | ||
| Q2 25 | -229.0% | -104.4% | ||
| Q1 25 | -781.1% | — | ||
| Q3 24 | — | -102.7% | ||
| Q2 24 | — | -112.3% | ||
| Q1 24 | -522.1% | — |
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.30 | $-0.02 | ||
| Q2 25 | $-0.18 | $-0.25 | ||
| Q1 25 | $-0.26 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.22 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | $6.2M |
| Stockholders' EquityBook value | $265.5M | $52.4M |
| Total Assets | $661.9M | $92.5M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $6.2M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $52.4M | ||
| Q3 25 | $265.5M | $44.7M | ||
| Q2 25 | $346.5M | $33.8M | ||
| Q1 25 | $371.1M | — | ||
| Q3 24 | $477.0M | $43.6M | ||
| Q2 24 | $527.8M | $56.8M | ||
| Q1 24 | $582.0M | — |
| Q4 25 | — | $92.5M | ||
| Q3 25 | $661.9M | $81.7M | ||
| Q2 25 | $721.0M | $78.0M | ||
| Q1 25 | $746.3M | — | ||
| Q3 24 | $827.5M | $69.3M | ||
| Q2 24 | $853.6M | $73.7M | ||
| Q1 24 | $901.4M | — |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | — |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $-67.9M | — | ||
| Q2 25 | $-72.8M | — | ||
| Q1 25 | $-75.6M | — | ||
| Q3 24 | $-76.7M | — | ||
| Q2 24 | $-51.1M | — | ||
| Q1 24 | $-40.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
